Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Chaoju Eye Care Holdings Ltd. ( (HK:2219) ).
Chaoju Eye Care Holdings Ltd. announced a new subscription of wealth management products worth RMB30 million through its subsidiary, Chaoju Medical Technology. This transaction, in combination with previous subscriptions, is considered a discloseable transaction under Hong Kong’s listing rules, indicating strategic financial management by utilizing surplus cash to potentially enhance returns.
The most recent analyst rating on (HK:2219) stock is a Buy with a HK$3.50 price target. To see the full list of analyst forecasts on Chaoju Eye Care Holdings Ltd. stock, see the HK:2219 Stock Forecast page.
More about Chaoju Eye Care Holdings Ltd.
Chaoju Eye Care Holdings Ltd. operates in the healthcare industry, focusing on eye care services. The company is involved in providing medical services related to eye health, leveraging its expertise to cater to patients’ needs in this specialized field.
Average Trading Volume: 692,513
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.18B
For a thorough assessment of 2219 stock, go to TipRanks’ Stock Analysis page.